kyvero
Market leaders

ITGR

Integer Holdings Corporation (ITGR)

Healthcare • Medical Devices

StockNYSEUnited StatesUS45826H1095

126.58 USD +0.13% today Updated 13 Nov 2026 15:33

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Integer Holdings Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 15:33. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 25 Feb 2027 in 104 days · 08:00 · estimate 1.45
Last results 1.34 vs 1.68 estimated 29 Oct 2026 · Miss -20.4%
Beat the estimate 9 of 12 2 missed · 1 in line
Average surprise +2.3% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

15 Feb 2024: estimate 1.33 15 Feb 2024: reported 1.39 02/24 25 Apr 2024: estimate 1.11 25 Apr 2024: reported 1.14 04/24 25 Jul 2024: estimate 1.23 25 Jul 2024: reported 1.30 07/24 24 Oct 2024: estimate 1.36 24 Oct 2024: reported 1.43 10/24 20 Feb 2025: estimate 1.46 20 Feb 2025: reported 1.43 02/25 24 Apr 2025: estimate 1.24 24 Apr 2025: reported 1.31 04/25 24 Jul 2025: estimate 1.55 24 Jul 2025: reported 1.55 07/25 23 Oct 2025: estimate 1.68 23 Oct 2025: reported 1.79 10/25 19 Feb 2026: estimate 1.70 19 Feb 2026: reported 1.76 02/26 30 Apr 2026: estimate 1.19 30 Apr 2026: reported 1.20 04/26 03 Aug 2026: estimate 1.38 03 Aug 2026: reported 1.60 08/26 29 Oct 2026: estimate 1.68 29 Oct 2026: reported 1.34 10/26

Estimate Reported: beat Reported: miss In line

Quarterly results

DateEPS estimateEPS reportedSurpriseResult
25 Feb 2027 08:00 1.45 — — Upcoming
29 Oct 2026 08:00 1.68 1.34 -20.4% Miss
03 Aug 2026 06:00 1.38 1.60 +15.8% Beat
30 Apr 2026 08:00 1.19 1.20 +1.1% Beat
19 Feb 2026 08:00 1.70 1.76 +3.6% Beat
23 Oct 2025 08:00 1.68 1.79 +6.8% Beat
24 Jul 2025 08:00 1.55 1.55 -0.1% In line
24 Apr 2025 08:00 1.24 1.31 +5.5% Beat
20 Feb 2025 08:00 1.46 1.43 -2.0% Miss
24 Oct 2024 08:00 1.36 1.43 +5.0% Beat
25 Jul 2024 08:00 1.23 1.30 +5.9% Beat
25 Apr 2024 08:00 1.11 1.14 +2.4% Beat
15 Feb 2024 08:00 1.33 1.39 +4.3% Beat
26 Oct 2023 08:00 1.10 1.27 +15.6% Beat
27 Jul 2023 08:00 1.00 1.14 +13.9% Beat
27 Apr 2023 08:00 0.83 0.87 +4.5% Beat
16 Feb 2023 08:00 1.09 1.11 +1.8% Beat
27 Oct 2022 08:00 0.88 0.95 +8.0% Beat
28 Jul 2022 08:00 1.14 1.04 -8.8% Miss
28 Apr 2022 08:00 0.95 0.78 -17.5% Miss
17 Feb 2022 08:00 0.96 0.99 +3.7% Beat
28 Oct 2021 08:00 0.92 1.05 +14.8% Beat
29 Jul 2021 08:00 0.92 1.07 +16.9% Beat
29 Apr 2021 08:00 0.84 0.97 +15.5% Beat
18 Feb 2021 08:00 0.61 0.71 +16.4% Beat
29 Oct 2020 08:00 0.34 0.50 +48.5% Beat
30 Jul 2020 08:00 0.36 0.32 -11.9% Miss
07 May 2020 17:00 1.13 1.25 +10.6% Beat
20 Feb 2020 08:00 1.18 1.25 +5.9% Beat
31 Oct 2019 08:00 1.07 1.20 +11.9% Beat
01 Aug 2019 08:00 1.06 1.23 +16.0% Beat
02 May 2019 08:00 0.81 1.00 +23.1% Beat
21 Feb 2019 08:00 0.94 1.04 +10.6% Beat
01 Nov 2018 08:00 0.93 1.06 +14.0% Beat
02 Aug 2018 08:00 0.88 1.06 +20.0% Beat
03 May 2018 16:00 0.70 0.61 -13.3% Miss
22 Feb 2018 16:00 0.79 0.96 +21.5% Beat
26 Oct 2017 16:00 0.80 0.82 +2.8% Beat
27 Jul 2017 16:00 0.73 0.62 -15.1% Miss
08 May 2017 16:00 0.59 0.41 -30.5% Miss
27 Feb 2017 16:00 0.85 0.87 +2.1% Beat
27 Oct 2016 16:00 0.79 0.83 +5.4% Beat
28 Jul 2016 16:00 0.76 0.56 -25.8% Miss
28 Apr 2016 16:00 0.50 0.34 -32.2% Miss
29 Feb 2016 16:00 0.80 0.92 +15.6% Beat
29 Oct 2015 16:00 0.47 0.58 +23.4% Beat
30 Jul 2015 16:00 0.63 0.64 +1.1% Beat
30 Apr 2015 16:00 0.56 0.54 -2.7% Miss
24 Feb 2015 16:00 0.60 0.65 +8.3% Beat
30 Oct 2014 16:00 0.58 0.64 +10.7% Beat

Annual results · USD

YearRevenueChangeNet income Net marginEPSEPS changeFree cash flow
2025 1.9B +8.0% 102.8M 5.5% 2.89 -14.0% 105.1M
2024 1.7B +10.3% 119.9M 7.0% 3.36 +24.9% 99.8M
2023 1.6B +16.9% 90.7M 5.8% 2.69 +35.2% 60.3M
2022 1.3B — 66.4M 5.0% 1.99 — 41.7M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Price history in USD, by week
PeriodOpening priceHighLow Closing priceChangeVolumeDividend
09 Nov 2026 – 13 Nov 2026 In progress 126.70 126.72 126.39 126.58 +0.02% 2,303,034
02 Nov 2026 – 06 Nov 2026 126.59 126.81 126.51 126.56 -0.02% 3,978,400
26 Oct 2026 – 30 Oct 2026 126.60 126.75 126.50 126.59 +0.04% 3,892,500
19 Oct 2026 – 23 Oct 2026 126.74 126.83 126.53 126.54 -0.13% 4,204,500
12 Oct 2026 – 16 Oct 2026 126.65 126.79 126.52 126.70 +0.07% 5,656,600
05 Oct 2026 – 09 Oct 2026 126.46 126.72 126.45 126.61 +0.13% 3,838,300
28 Sep 2026 – 02 Oct 2026 126.28 126.54 126.23 126.45 +0.09% 4,817,700
21 Sep 2026 – 25 Sep 2026 126.53 126.53 126.16 126.34 +0.05% 3,152,500
14 Sep 2026 – 18 Sep 2026 126.30 126.54 126.10 126.28 +0.22% 3,895,500
08 Sep 2026 – 11 Sep 2026 126.30 126.45 125.86 126.00 -0.40% 2,697,500
253 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close
126.42 USD
Market cap
4.3B
Exchange
NYSE
Country
United States
Sector
Healthcare
Industry
Medical Devices
Currency
USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the scorePointsWhy
Business growth Yearly growth of revenue and of earnings per share. 20.8 / 25
  • Revenue growth of 11.7% a year
  • Earnings per share growth of 13.2% a year
Quality Return on equity, net margin and how stable the margins are. 10.7 / 25
  • ROE of 6%
Financial strength Net debt against operating earnings, interest cover and free cash flow. 12.3 / 20
  • Net debt is 4.2× EBITDA
  • Free cash flow yield of 2.0%
Valuation Free cash flow yield and the P/E against its sector. 4.2 / 15
  • P/E 42.5 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price. 3.4 / 10
  • Analysts' target is +0% from the price
  • Heavy debt: net debt is 4.2× EBITDA
  • Total debt has risen three years in a row

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
FigureValueReading Sector median
P/E (trailing) 42.51× Weak 30.56×
P/E (forward) 18.44× Fair 14.16×
Price / book 2.49× Fair 3.5×
Price / sales 2.36× Fair 3.33×
EV / EBITDA 17.7× Weak 11.19×
Free cash flow yield 2% Weak 2.1%
Quality
FigureValueReading Sector median
Gross margin 25.1% Fair 54.9%
Operating margin 9.8% Fair 5.8%
Net margin 5.7% Fair 1.2%
Return on equity 6% Weak 4.4%
Return on assets 3.3% Fair 2.7%
Growth
FigureValueReading Sector median
Revenue growth / year 11.7% Good 10.1%
EPS growth / year 13.2% Good 10.2%
Financial health
FigureValueReading Sector median
Debt / equity 0.78× Good 0.4×
Net debt / EBITDA 4.18× Weak 1.46×
Interest cover 6.58× Fair 2.17×
Current ratio 3.99× Good 2.64×
Dividends
FigureValueReading Sector median
Payout of earnings 0% Weak 0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow ITGR and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in